These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38503394)

  • 1. Diurnal cortisol, neuroinflammation, and neuroimaging visual rating scales in memory clinic patients.
    Holleman J; Daniilidou M; Kåreholt I; Aspö M; Hagman G; Udeh-Momoh CT; Spulber G; Kivipelto M; Solomon A; Matton A; Sindi S
    Brain Behav Immun; 2024 May; 118():499-509. PubMed ID: 38503394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of multiple visual rating scales based on structural magnetic resonance imaging with disease severity and cerebrospinal fluid biomarkers in patients with Alzheimer's disease.
    Wan MD; Liu H; Liu XX; Zhang WW; Xiao XW; Zhang SZ; Jiang YL; Zhou H; Liao XX; Zhou YF; Tang BS; Wang JL; Guo JF; Jiao B; Shen L
    Front Aging Neurosci; 2022; 14():906519. PubMed ID: 35966797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortisol, cognition and Alzheimer's disease biomarkers among memory clinic patients.
    Holleman J; Adagunodo S; Kåreholt I; Hagman G; Aspö M; Udeh-Momoh CT; Solomon A; Kivipelto M; Sindi S
    BMJ Neurol Open; 2022; 4(2):e000344. PubMed ID: 36277478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroinflammation, cerebrovascular dysfunction and diurnal cortisol biomarkers in a memory clinic cohort: Findings from the Co-STAR study.
    Daniilidou M; Holleman J; Hagman G; Kåreholt I; Aspö M; Brinkmalm A; Zetterberg H; Blennow K; Solomon A; Kivipelto M; Sindi S; Matton A
    Transl Psychiatry; 2024 Sep; 14(1):364. PubMed ID: 39251589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automatically computed rating scales from MRI for patients with cognitive disorders.
    Koikkalainen JR; Rhodius-Meester HFM; Frederiksen KS; Bruun M; Hasselbalch SG; Baroni M; Mecocci P; Vanninen R; Remes A; Soininen H; van Gils M; van der Flier WM; Scheltens P; Barkhof F; Erkinjuntti T; Lötjönen JMP;
    Eur Radiol; 2019 Sep; 29(9):4937-4947. PubMed ID: 30796570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Price of Stress: High Bedtime Salivary Cortisol Levels Are Associated with Brain Atrophy and Cognitive Decline in Stroke Survivors. Results from the TABASCO Prospective Cohort Study.
    Tene O; Hallevi H; Korczyn AD; Shopin L; Molad J; Kirschbaum C; Bornstein NM; Shenhar-Tsarfaty S; Kliper E; Auriel E; Usher S; Stalder T; Ben Assayag E
    J Alzheimers Dis; 2018; 65(4):1365-1375. PubMed ID: 30149451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combining visual rating scales to identify prodromal Alzheimer's disease and Alzheimer's disease dementia in a population from a low and middle-income country.
    Custodio N; Malaga M; Chambergo-Michilot D; Montesinos R; Moron E; Vences MA; Huilca JC; Lira D; Failoc-Rojas VE; Diaz MM
    Front Neurol; 2022; 13():962192. PubMed ID: 36119675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Cortical Atrophy and White Matter Lesions Between Dementia With Lewy Bodies and Alzheimer's Disease: A Case-Control Study.
    Zhu H; Lu H; Wang F; Liu S; Shi Z; Gan J; Du X; Yang Y; Li D; Wang L; Ji Y
    Front Neurol; 2021; 12():779344. PubMed ID: 35087466
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of MR Visual Rating Scales in Major Forms of Dementia.
    Kaushik S; Vani K; Chumber S; Anand KS; Dhamija RK
    J Neurosci Rural Pract; 2021 Jan; 12(1):16-23. PubMed ID: 33531755
    [No Abstract]   [Full Text] [Related]  

  • 11. A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer's disease in a Chinese population.
    Wei M; Shi J; Ni J; Zhang X; Li T; Chen Z; Zhou M; Zhang L; Tan Z; Wang Y; Tian J
    BMC Geriatr; 2019 Feb; 19(1):59. PubMed ID: 30819102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Life-course stress, cognition, and diurnal cortisol in memory clinic patients without dementia.
    Holleman J; Kåreholt I; Aspö M; Hagman G; Udeh-Momoh CT; Kivipelto M; Solomon A; Sindi S
    Arch Gerontol Geriatr; 2024 Apr; 119():105316. PubMed ID: 38134708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does posterior cortical atrophy on MRI discriminate between Alzheimer's disease, dementia with Lewy bodies, and normal aging?
    O'Donovan J; Watson R; Colloby SJ; Firbank MJ; Burton EJ; Barber R; Blamire AM; O'Brien JT
    Int Psychogeriatr; 2013 Jan; 25(1):111-9. PubMed ID: 22809815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship Between General Cognition, Visual Assessed Cortical Atrophy, and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease: A Cross-Sectional Study from a Chinese PUMCH Cohort.
    Mao C; Sha L; Li J; Huang X; Chu S; Lei D; Wang J; Dong L; Liu C; Xu Q; Peng B; Gao J
    J Alzheimers Dis; 2021; 82(1):205-214. PubMed ID: 34024840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
    Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
    Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Ouanes S; Rabl M; Clark C; Kirschbaum C; Popp J
    Alzheimers Res Ther; 2022 Dec; 14(1):190. PubMed ID: 36529757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and clinical correlation of practical cut-offs for visual rating scales of atrophy: normal aging versus mild cognitive impairment and Alzheimer's disease.
    Vanhoenacker AS; Sneyers B; De Keyzer F; Heye S; Demaerel P
    Acta Neurol Belg; 2017 Sep; 117(3):661-669. PubMed ID: 28397182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical applicability of quantitative atrophy measures on MRI in patients suspected of Alzheimer's disease.
    Ingala S; van Maurik IS; Altomare D; Wurm R; Dicks E; van Schijndel RA; Zwan M; Bouwman F; Schoonenboom N; Boelaarts L; Roks G; van Marum R; van Harten B; van Uden I; Claus J; Wottschel V; Vrenken H; Wattjes MP; van der Flier WM; Barkhof F
    Eur Radiol; 2022 Nov; 32(11):7789-7799. PubMed ID: 35639148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting amyloid-PET status in a memory clinic: The role of the novel antero-posterior index and visual rating scales.
    Zilioli A; Misirocchi F; Pancaldi B; Mutti C; Ganazzoli C; Morelli N; Pellegrini FF; Messa G; Scarlattei M; Mohanty R; Ruffini L; Westman E; Spallazzi M
    J Neurol Sci; 2023 Dec; 455():122806. PubMed ID: 38006829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
    Nho K; Kueider-Paisley A; Ahmad S; MahmoudianDehkordi S; Arnold M; Risacher SL; Louie G; Blach C; Baillie R; Han X; Kastenmüller G; Trojanowski JQ; Shaw LM; Weiner MW; Doraiswamy PM; van Duijn C; Saykin AJ; Kaddurah-Daouk R;
    JAMA Netw Open; 2019 Jul; 2(7):e197978. PubMed ID: 31365104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.